Combination therapy for multiple sclerosis in children
The efficiency of combination therapy for multiple sclerosis was evaluated in 40 children aged 10 to 17 years. Two groups matched for major clinical and laboratory parameters were treated every 6 months during 3 years. Both groups received one cascade plasma filtration session using plasma Evaflux 2...
Main Authors: | N. V. Skripchenko, G. P. Ivanova, A. V. Surovtseva, E. Yu. Skripchenko, K. V. Serednyakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ltd. “The National Academy of Pediatric Science and Innovation”
2016-04-01
|
Series: | Rossijskij Vestnik Perinatologii i Pediatrii |
Subjects: | |
Online Access: | https://www.ped-perinatology.ru/jour/article/view/303 |
Similar Items
-
Comparative characteristic of laboratory indicators for encephalitis, disseminated encephalomyelitis and multiple sclerosis in children
by: E. Y. Skripchenko, et al.
Published: (2018-11-01) -
Multimodal evoked potentials and transcranial magnetic stimulation in diagnostics of children with encephalitis, acute disseminated encephalomyelitis and multiple sclerosis
by: E. Yu. Skripchenko, et al.
Published: (2018-04-01) -
Dynamics of quality of life indicators at a multiple sclerosis
by: V. N. Karnaukh, et al.
Published: (2010-08-01) -
NEUROPHYSIOLOGY PARAMETERS IN DIAGNOSTICS OF MULTIPLE SCLEROSIS AND ACUTE DISSEMINATED ENCEPHALOMYELITIS IN CHILDREN
by: V. B. Voitenkov, et al.
Published: (2017-06-01) -
Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
by: I. V. Smagina, et al.
Published: (2010-08-01)